BRCA1


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to BRCA1: BRCA2

BRCA1

n.
A gene that is associated with the development of familial breast cancer when inherited in a defective state.

[br(east) ca(ncer) 1.]
Mentioned in ?
References in periodicals archive ?
This is concerning, a press statement by the National Society of Genetic Counselors says, because "although there is limited research, taking female hormones may increase breast cancer risk in transgender women, especially those with a BRCA1 or BRCA2 mutation.
It is dubbed the Jolie gene after actress Angelina Jolie, who had a double mastectomy and her ovaries removed after discovering she had a faulty BRCA1 gene.
When BRCA1 is unable to carry out its duties as a tumor suppressor, cancerous cells can proliferate.
55 breast cancer patients and 51 at risk individuals undergoing BRCA1 and BRCA2 full sequencing in Marmara University, Medical Genetics Laboratory from 2015 to 2016 were included in this study.
5% of all ovarian cancer patients carry a single BRCA1 mutation known to be a Colombian founder mutation (5-8).
Tumours with faulty BRCA1 and BRCA2 genes in breast and ovarian cancers are treated with PARP inhibitors which are drugs that have been designed to specifically target these gene mutations.
One of the great mysteries in cancer research is why inherited mutations, such as those in BRCA1, cause cancer only in specific tissues such as the breast and ovaries, rather than in all tissues.
1, 2, 12 exons) and 3' region (C terminal, 18, 19, 20, 21, 22 exons) of BRCA1 gene which comprised of 1812bp, 1128bp and 2024bp, respectively was also performed.
BRCA1 es un gen supresor de tumores humanos, que regula el ciclo celular y evita la proliferacion incontrolada.
This newly defined risk, the first to show a conclusive link between the BRCA1 gene mutation and a small but significant chance of developing an aggressive uterine cancer, could become a consideration in weighing treatment options.
Among women with BRCA1 mutations, however, there was increased risk for serous/serouslike endometrial carcinomas, which comprise only 10% of endometrial cancers, but account for about 40% of endometrial cancer deaths, reported Catherine A.